Marko Popovic

Retina Specialist @unityhealthTO, Medical Retina Fellowship @ucla, Ophthalmology Residency @uoftpgme, MPH @HarvardChanSPH, MD @uoftmedicine, BHSc @MacHealthSci

[Ophthalmology @AAOjournal]

Ophthalmic herpes infections were not associated with an increased risk of malignancy in the overall cohort. However, herpes zoster ophthalmicus was associated with a higher subsequent risk of cancer among individuals with preexisting immune dysregulation.
https://t.co/P3v4mAbxX1
@AndrewMihalache @PopovicMM @RSTHuang

[Ophthalmology @AAOjournal]

Fuchs’ Endothelial Corneal Dystrophy and Cardiometabolic Comorbidities
https://t.co/MRpE3ECA7h
@AndrewMihalache @RSTHuang @PopovicMM
#ophthalmology

[JAMA Ophthalmology @JAMAOphth]

DeepSeek-R1 demonstrated superior performance compared to #OpenAI o1 in clinical diagnosis and management across subspecialties, while also reducing operating costs. https://t.co/FomIrl2uTw @DanielMiladMD @FaresAntaki @theMichaelBalas @pearsekeane

[Temerty Medicine @uoftmedicine]

#TemertyMed study finds patients with diabetes-related eye disease who are male, Black or Hispanic, or live farther away are more likely to miss follow-up, raising risk of vision loss. https://t.co/oJGbOzOKYY

[Retina @RetinaJournal]

LARGE RETINAL CAPILLARY ANEURYSM
A Delphi Consensus Study and Updated Nomenclature for a Signature Optical Coherence Tomography Lesion
Popovic, Marko M. MD, MPH; et. al.
Retina 45(8):p 1451-1459, August 2025
https://t.co/CrBOTUIWBA
#retina
@PopovicMM

[Retina @RetinaJournal]

ADAPTIVE OPTICS IN RETINITIS PIGMENTOSA
Mihalache, Andrew MD(C); et. al.
Retina 45(7):p 1375-1388, July 2025
https://t.co/S9RFgmM0OY
#retina
@AndrewMihalache @RSTHuang @PopovicMM @BrianBallios @RaHMu123

[Marko Popovic @PopovicMM]

Thank you ABC News Australia @abcnews for interviewing me about our study on GLP1 drugs and macular degeneration! Was a pleasure discussing this study with you! Link: https://t.co/xa3Ch6t222

[Marko Popovic @PopovicMM]

Thank you @Bloomberg for featuring our study on the association between GLP-1 drugs and macular degeneration!

https://t.co/9YdlzuveU8

[JAMA Ophthalmology @JAMAOphth]

Most viewed this week from @JAMAophth:

More than twice as many patients with diabetes exposed to glucagon-like peptide-1 receptor agonists developed neovascular age-related macular degeneration compared with matched controls.

https://t.co/NZRAsLZ83j

[Retina @RetinaJournal]

QUANTITATIVE FLUORESCEIN ANGIOGRAPHY BIOMARKERS IN DIABETIC MACULAR EDEMA
Huang, Ryan S. MSc, MD(C); et. al.
Retina 45(6):p 1125-1133, June 2025
https://t.co/W92XM3gxzp
#retina
@RSTHuang @AndrewMihalache @PopovicMM @RaHMu123

[Marko Popovic @PopovicMM]

@davidasinclair Thank you @davidasinclair for featuring our study. We encourage further research to investigate the exact mechanisms involved. We must be vigilant of these potential risks. Patients on GLP-1 receptor agonists with new vision symptoms should be seen by an ophthalmologist.

[Marko Popovic @PopovicMM]

@EricTopol Thank you @EricTopol for featuring our study. We encourage further research in this area to investigate the exact mechanisms involved. We must be vigilant of these potential risks. Patients on GLP-1 receptor agonists with new vision symptoms should be seen by an ophthalmologist.

[David Sinclair @davidasinclair]

NEW STUDY: More than twice as many diabetic patients exposed to GLP-1 RAs (Ozempic, Wagovy, Mounjaro) developed age-related macular degeneration https://t.co/IYAYud82L6

[Unity Health Toronto @UnityHealthTO]

A new study suggests GLP-1 medicines such as Ozempic are associated with greater risk of developing age-related macular degeneration. Read more via @guardian @PopovicMM, @RaHMu123, @RaHMu123
@AndrewMihalache, @NooriAtefeh, @RKohly

https://t.co/ilH9k97Ry8

[JAMA Ophthalmology @JAMAOphth]

More than twice as many patients with diabetes exposed to glucagon-like peptide-1 receptor agonists developed neovascular age-related macular degeneration compared with matched controls.

https://t.co/TCXnrXbb8X

[Eric Topol @EricTopol]

The potential risk of age-related macular degeneration with GLP-1 drugs in people with diabetes
https://t.co/BoGo9iTutV

[PSI Foundation @PSIFoundation]

Dr. @PopovicMM (@uoftmedicine)'s study on preoperative fasting for ambulatory #Cataract surgery: a time-interrupted prospective study (The PRACTICE Study): https://t.co/DOWnQY2t5w #VisionHealthMonth #EyeHealth

[Retina @RetinaJournal]

SOCIAL DETERMINANTS OF HEALTH IN AGE-RELATED MACULAR DEGENERATION
A Nationally Representative Survey Study
Huang, Ryan S.; et. al.
Retina 45(4):p 703-713, April 2025
https://t.co/MyCmDDIGTl
#retina
@RSTHuang @AndrewMihalache @Jim_XCS @PopovicMM @RaHMu123 @RKohly @UofTDOVS

[Ophthalmology @AAOjournal]

Infants receiving ranibizumab more likely to require re-treatment but had lower refractive error, with no significant difference in complication rates compared to infants who received laser photocoagulation (GRADE: moderate-low). https://t.co/WlogS92mLz
@a_baiad7 @popovicMM

[JAMA Ophthalmology @JAMAOphth]

While most ophthalmology journals have adopted guidelines on generative artificial intelligence (GenAI), this study found variability in their scope and comprehensiveness. https://t.co/tmvZ1TXXX0